Lannett Company (LCI)

4.09 +0.01  +0.25%  May 30, 10:02AM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

Lannett Company R&D Expense: 2.912M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

LCI R&D Expense Rankings

Overall 55th percentile 791 of 1763
Sector 64th percentile 146 of 413 in Healthcare
Industry 69th percentile 12 of 39 in Drug Manufacturers - Other

LCI R&D Expense Range, Past 5 Years

Minimum 0.9463M Dec 2007
Maximum 3.352M Mar 2010
Average 2.158M

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

You may also be interested in these LCI related companies

Display in Live Stream: Done
Options

LCI News

$LCI forms bullish &quot;Continuation Wedge&quot; chart pattern. http://stks.co/3mUO
about 19 days ago by RecogniaEvents
$LCI filed latest Quarterly Report http://stks.co/3kWp
about 21 days ago by MarketBrief
Lannett Comp (LCI) Tops Q1 EPS by 2c
May 08, 4:32PM Street Insider
$LCI 3QFY12 EPS $0.06 Rev $30.7M (+19%) vs. yr-ago loss of ($0.01) and $25.9M //hopefully some movement now
about 22 days ago by wcesq
$LCI earnings this afternoon FYI
about 22 days ago by wcesq
$LCI forms bullish &quot;Continuation Wedge&quot; chart pattern. http://stks.co/3Ulq
about 35 days ago by RecogniaEvents
LANNETT CO INC Financials
Feb 15, 1:04PM
FDA Outlines Path For Generic Biotech Drugs. http://stks.co/2MP0 $MYL $ENDP $TEVA $WPI $PRX $HITK $LCI $EPCT $ABT $PFE
about 109 days ago by abubnic
$LCI filed latest Quarterly Report http://stks.co/2KpR
about 111 days ago by MarketBrief
$LCI filed latest Quarterly Report http://stks.co/2JMN
about 112 days ago by MarketBrief
Lannett Comp (LCI) Misses Q2 EPS by 1c
Feb 07, 4:02PM Street Insider
Obseity control drug approved by FDA, second approval in a week, $LCI 5.22+0.13
about 117 days ago by silverjet2
$LCI today announced FDA approval of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
about 121 days ago by silverjet2
Low-debt growth $LCI held by insiders and $$$ managers, should have a +ve 2012 with recent FDA approvals and increased production, Long
about 124 days ago by silverjet2
Lannett reprimanded by NYSE
Dec 22, 10:55AM
$LCI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/1ZJY
about 167 days ago by MarketBrief
LANNETT CO INC Financials
Nov 10, 1:04PM
$LCI filed latest Quarterly Report http://stks.co/ySy
about 208 days ago by MarketBrief
Lannett Comp (LCI) Misses Q1 EPS by 1c
Nov 03, 5:20PM Street Insider
Lannett reports Q3 EPS 1c vs. consensus 2c
Nov 03, 4:02PM FlyOnTheWall
Lannett management to meet with Roth Capital
Oct 20, 8:30PM FlyOnTheWall
Lannett $LCI gets FDA approval for loxapine capsules in 5, 10, 25 and 50 MG
about 246 days ago by Street_Insider
$LCI--CEO purchased 20,467 shares at $3.90. Stock trading at $3.95. Do your own research, low floater.
about 261 days ago by MicroInsider
$LCI CFO resigning
about 302 days ago by bricktop13
$LCI initated position at 4.70, looking for .50-1.00 in 2 weeks on drug approval, possible buyout
about 317 days ago by CollegeStockTrader
Holding $LCI for next #approval
about 336 days ago by TylerTrimbath
$LCI takes a 5% hit after #FDA approval. Has several more to go? Strange reaction. Crazy Monday!
about 338 days ago by msgtretusaf
$LCI....fundies ae ok.....need more liquidity, higher price action before I play this one.
about 341 days ago by BreakoutTheory
$LCI if no PR pre market buying more on open
about 341 days ago by TylerTrimbath
$LCI The FDA must be backed up hope it&#39;s out tomorrow morning traded low volume after hours
about 341 days ago by TylerTrimbath
Holding $LCI waiting for the release
about 342 days ago by TylerTrimbath
$DVAX, $LCI upcoming decision. Looking to roll into $PATH
about 345 days ago by TylerTrimbath
$LCI http://chart.ly/w3fakr6 looks flushable
about 346 days ago by traderdigs

Recent Quotes

Symbol Price Chg Chg % Market Cap
LCI 4.09 +0.01 +0.25% 115.71M
LCC 12.66 +0.04 +0.28% 2.046B
JPM 33.15 -0.48 -1.43% 128.38B
JPG 12.77 -0.07 -0.55%
JOY 59.10 -3.22 -5.17% 6.675B
JOUT 18.15 -0.13 -0.71% 180.42M
JOSB 44.62 -3.17 -6.63% 1.330B
JOEZ 1.04 -0.03 -2.80% 69.43M
JOE 16.53 -0.41 -2.42% 1.563B
JOBS 46.11 -1.09 -2.31% 1.337B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close